iBio, Inc. — Cash Flow Charts
14 years of history · ending 2025-06-30 · SEC EDGAR
Operating Cash Flow↑+49.1% +$15M
$-15M
Free Cash Flow↑+56.2% +$20M
$-15M
Investing Cash Flow↑+102.8% +$27M
$742K
Financing Cash Flow↓-88.7% -$70M
$9M
Capex↓-99.7% -$5M
$16K
Acquisitions
$692K
Stock-Based Comp↓-3.5% -$56K
$2M
D&A↑+2.5% +$12K
$484K